With shifts in legislation and pricing reforms shaking the industry, pressure to support evidence requirements to expedite access to treatment has intensified. With payer expectations changing more so than ever before, pharma must create compelling evidence plans to fast-track their place in the market. 

Join our latest webinar to learn how to build frameworks that will accelerate access. We'll show you how to enhance real world data, understand evolving payer needs and innovate our value frameworks to provide a stable ground for pre and post drug launch.

Hear from AstraZeneca, Sanofi, Takeda and Novartis share:

• Tailor your products value proposition by having early conversations with committees, advocacy groups and ad boards.
• Craft a robust evidence plan that will expedite product launch enabling a competitive edge in the market. 
• Harness patient-focused real world data that will strengthen payer value and accelerate access to medication. 
• More than drugmakers: Open new channels of business by creating new concepts of value, such as indicating health equity as a criteria.